Live Breaking News & Updates on Minghui Ren

Stay updated with breaking news from Minghui ren. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

WHO launches Global Initiative on Arboviruses

Geneva, Apr 1 (Prensa Latina) The World Health Organization (WHO) launched the Global Initiative on Arboviruses in order to increase surveillance, detection and response to these diseases located mostly in tropical and subtropical areas, it was announced today. ....

Minghui Ren , Michael Ryan , Sylvie Briand , Health Coverage , Department Of Pandemic , Global Arbovirus Initiative , Department Of Immunization , Department Of Control Neglected Tropical Diseases , Global Health Emergencies Program , Emergencies Program , Epidemic Diseases , Universal Health Coverage , Non Communicable Diseases , Neglected Tropical Diseases ,

Increased access to testing, treatment has reduced hepatitis C in low- and middle-income countries


Increased access to testing, treatment has reduced hepatitis C in low- and middle-income countries
Many low- and middle-income countries have reduced suffering from hepatitis C, thanks to increased access to testing and treatment. Some achieved a 20-fold increase in the number of people treated with safe and effective direct-acting retroviral drugs between 2015 and 2018, according to the
Global progress report on accelerating access to hepatitis C diagnostics and treatment, released by WHO today.
A drop in prices underpins this success
Low- and middle-income countries can now aim to achieve a price as low as US$ 60 per patient for a 12-week course of treatment with WHO-prequalified generic sofosbuvir and daclatasvir. Prices offered by suppliers of WHO-prequalified HCV rapid diagnostic tests ranged between US$ 1 and US$ 8 per test. ....

Minghui Ren , Mariangela Simao , Meg Doherty , Emily Henderson , Department Of Global , Health Coverage Communicable , Global Health Sector Strategy On Viral Hepatitis , Health Products , Global Health Sector Strategy , Viral Hepatitis , Assistant Director General Access , Hepatitis C , மெக் டோவர்டீ , எமிலி ஹென்டர்சன் , துறை ஆஃப் உலகளாவிய , ஆரோக்கியம் பாதுகாப்பு தொடர்பு கொள்ளக்கூடியது , உலகளாவிய ஆரோக்கியம் துறை மூலோபாயம் ஆன் வைரஸ் ஹெபடைடிஸ் , ஆரோக்கியம் ப்ராடக்ட்ஸ் , உலகளாவிய ஆரோக்கியம் துறை மூலோபாயம் , வைரஸ் ஹெபடைடிஸ் , உதவியாளர் இயக்குனர் ஜநரல் நுழைவு , சர்வதேச பரவல் ,

WHO on progress in access to hepatitis C diagnostics and treatment


Date Time
WHO on progress in access to hepatitis C diagnostics and treatment
Many low- and middle-income countries have reduced suffering from hepatitis C, thanks to increased access to testing and treatment. Some achieved a 20-fold increase in the number of people treated with safe and effective direct-acting retroviral drugs between 2015 and 2018, according to the Global progress report on accelerating access to hepatitis C diagnostics and treatment, released by WHO today.
A drop in prices underpins this success
Low- and middle-income countries can now aim to achieve a price as low as US$ 60 per patient for a 12-week course of treatment with WHO-prequalified generic sofosbuvir and daclatasvir. Prices offered by suppliers of WHO-prequalified HCV rapid diagnostic tests ranged between US$ 1 and US$ 8 per test. ....

Minghui Ren , Mariangela Simao , Meg Doherty , Department Of Global , Health Coverage Communicable , Global Health Sector Strategy On Viral Hepatitis , Health Products , Global Health Sector Strategy , Viral Hepatitis , Assistant Director General Access , மெக் டோவர்டீ , துறை ஆஃப் உலகளாவிய , ஆரோக்கியம் பாதுகாப்பு தொடர்பு கொள்ளக்கூடியது , உலகளாவிய ஆரோக்கியம் துறை மூலோபாயம் ஆன் வைரஸ் ஹெபடைடிஸ் , ஆரோக்கியம் ப்ராடக்ட்ஸ் , உலகளாவிய ஆரோக்கியம் துறை மூலோபாயம் , வைரஸ் ஹெபடைடிஸ் , உதவியாளர் இயக்குனர் ஜநரல் நுழைவு ,

WHO highlights progress in accelerating access to hepatitis C diagnostics and treatment in low- and middle-income countries


WHO highlights progress in accelerating access to hepatitis C diagnostics and treatment in low- and middle-income countries
WHO / Blink Media - Martyn Aim
©
Credits
WHO highlights progress in accelerating access to hepatitis C diagnostics and treatment in low- and middle-income countries
27 January 2021
Reading time:
Many low- and middle-income countries have reduced suffering from hepatitis C, thanks to increased access to testing and treatment. Some achieved a 20-fold increase in the number of people treated with safe and effective direct-acting retroviral drugs
between 2015 and 2018, according to the
A drop in prices underpins this success
Low- and middle-income countries can now aim to achieve a price as low as US$ 60 per patient for a 12-week course of treatment with WHO-prequalified generic sofosbuvir and daclatasvir. Prices offered by suppliers of WHO-prequalified HCV rapid diagnostic ....

Minghui Ren , Mariangela Simao , Meg Doherty , Department Of Global , Health Coverage Communicable , Global Health Sector Strategy On Viral Hepatitis , Health Products , Global Health Sector Strategy , Viral Hepatitis , Assistant Director General Access , மெக் டோவர்டீ , துறை ஆஃப் உலகளாவிய , ஆரோக்கியம் பாதுகாப்பு தொடர்பு கொள்ளக்கூடியது , உலகளாவிய ஆரோக்கியம் துறை மூலோபாயம் ஆன் வைரஸ் ஹெபடைடிஸ் , ஆரோக்கியம் ப்ராடக்ட்ஸ் , உலகளாவிய ஆரோக்கியம் துறை மூலோபாயம் , வைரஸ் ஹெபடைடிஸ் , உதவியாளர் இயக்குனர் ஜநரல் நுழைவு ,